From: Physical activity assessment by accelerometry in people with heart failure
Characteristic | N = 22 patients Mean ± SD unless otherwise stated |
---|---|
Male (n, %) | 17 (77) |
Age (years) | 70.7 ± 14.1 |
Body Mass Index (kg/m2) | 28.1 ± 4.4 |
LVEF (%) | 34.5 ± 14.0 |
Reduced LVEF < 40% (n, %) | 14 (64) |
Mid-range LVEF 40–49% (n, %) | 4 (18) |
Preserved EF ≥50% (n, %) | 4 (18) |
NYHA class (n, %) | |
 I | 1 (4) |
 II | 18 (82) |
 III | 3 (14) |
 IV | 0 |
Dilated cardiomyopathy (n, %) | 14 (64) |
Ischaemic heart disease (n, %) | 8 (36) |
ICD/CRT/Pacemaker (n, %) | 13 (59) |
ACE-I/ARB/ARNI (n, %) | 21 (95) |
Beta-blocker (n, %) | 22 (100) |
MRA (n, %) | 14 (64) |
Loop diuretic (n, %) | 17 (77) |
Hypertension (n, %) | 11 (50) |
Diabetes (n, %) | 6 (27) |
COPD (n, %) | 4 (18) |
Arthritis (n, %) | 2 (9) |
AF (n, %) | 11 (50) |
Stroke (n, %) | 5 (23) |
Comorbidities (hypertension, diabetes, COPD, arthritis, AF, stroke) (n, %) | |
 0 comorbidity | 6 (27) |
 1 comorbidity | 4 (18) |
 2 comorbidities | 5 (23) |
 3 comorbidities | 4 (18) |
 4+ comorbidities | 3 (14) |
ISWT distance (m) | 286.4 ± 190.6 |
RMR (mL O2·kg−1·min−1) | 2.67 ± 0.66 |